Dr Julio Reinecke

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Despite the high prevalence of the disease, at present little effective pharmacological treatment of rheumatoid arthritis is available. Novel approaches utilising biological agents have resulted in the development of new antiarthritic and antiinflammatory agents, such as tumour necrosis factor-α (TNFα)-specific antibodies and interleukin-1 receptor(More)
  • 1